Epidermolysis Bullosa Dystrophica, Recessive

Dermatology·MeSH: Corneal Injuries

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Epidermolysis Bullosa Dystrophica, Recessive?

There are 1 clinical trial targeting Epidermolysis Bullosa Dystrophica, Recessive tracked by BioSniper.

What is the prevalence of Epidermolysis Bullosa Dystrophica, Recessive?

The estimated prevalence of Epidermolysis Bullosa Dystrophica, Recessive is approximately 0.1 per 100,000 population.

Deep-dive into Epidermolysis Bullosa Dystrophica, Recessive

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Epidermolysis Bullosa Dystrophica, Recessive — Drugs in Development & Clinical Trials | BioSniper